Landscapes / Targets

TP53

9 drugs act on TP53, in 9 active trials · Any stage · updated 20 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs9

DrugHow it worksCompanyStageNext dateDetails
Bruton's tyrosine kinase inhibitor
Merck & Co. · Public MRK
Phase 3 19 May 2027Phase 3 trial completes
PD-1 antibody
Merck & Co. · Public MRK
Phase 1/2 15 Dec 2026soonPhase 1/2 trial completes
—
Phase 1/2 15 Dec 2026soonPhase 1/2 trial completes
—
Phase 1/2 Jan 2027Phase 1/2 trial completes
—
Phase 1/2 Dec 2028Phase 1/2 trial completes
—
Phase 1/2 30 Dec 2029Phase 1/2 trial completes
—
Phase 1/2 31 Oct 2032Phase 1/2 trial completes
—
Phase 1 Dec 2027Phase 1 trial completes
—
AstraZeneca · Public AZN
Phase 1 31 Jul 2029Phase 1 trial completes

About this list

Checked
9 of 9 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 20 Nov 2026 · openFDA updated 20 Nov 2026

Follow TP53

Following is part of Solo: you see every change to TP53 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in